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Estimating the Elasticity of Drug Pricing and
Medicare/Medicaid Beneficiary Count
Bryan Kelleher, Sacred Heart University

Research Questions
1. Does the average cost share impact
the overall beneficiary count of
Medicare/Medicaid?
2. How does Low Income Subsidy
(LIS) affect the relationship between
cost share and beneficiaries?

3. Is the relationship of the LIS
group more adversely affected than
the non LIS group?

Motivation
With the healthcare industry under
the spotlight in America today, my
mission was to highlight a
relationship between two key
issues of the twenty-first century:
Pharmaceutical Drug Pricing, and
Medicare/Medicaid.
• With the elderly population
booming in our society, I found it
important to look into Medicare
as it requires beneficiaries to be
older than 65 in order to receive
full Medicare.
• The pharmaceutical industry has
faced scrutiny over the price
gouging that occurs on all types
of medication. I wanted to see
how the pricing would effect the
Medicare/Medicaid patients.

Research Design
Using Drug Spending data from the Center for Medicare/Medicaid
Services, I developed an equation to estimate the relationship
between the overall average beneficiary cost-share and the
beneficiary count. In addition to this, I addressed the subsections
in the dataset, Low Income Subsidy and No Low Income Subsidy.
Low Income Subsidy is an assistance program for low income
patients who do not fall into other subsidy groups. The eligibility for
this varies per state and is assessed based on income. I use
these as dependent variables to determine their relationship with
the relative cost share. In these equations I controlled for; Total
Revenue to drug manufacturer (Unit count x average price per
unit) as well as whether a generic or biosimilar version was
available during any point between 2010 and 2015.

Results
The Average Beneficiary Cost-Share for the overall Beneficiary
Count showed that for every dollar the cost share is raised, the
beneficiary count decreases by 19.15 people. When assessing the
subgroups, the LIS group had results that were statistically
insignificant, likely due to the small population within the group itself.
On the other hand, the No LIS group was significant showing for
every dollar Cost-Share is raised, the beneficiary count decreases
18.53 people. This number closely resembles the overall relationship
between cost-share and beneficiary count.

Conclusions
The purpose of this research is to
estimate the relationship of costshare and beneficiary count for
Medicare/Medicaid patients.
Further, the subgroups: Low
Income Subsidy and No Low
Income Subsidy were analyzed to
see if the relationship differed
based on assistance given by the
Center for Medicare Services.
Overall, the results suggest a
negative correlation between costshare and beneficiary count in the
overall average and No LIS
subgroup. This study contributes to
the field by using recent data
released by the Center for Medicare
Services. In addition, it provides
useful information to the Center for
Medicare Services that allows them
to estimate their change in
beneficiary count when adjusting
the cost-share based on the results
of this study.
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